Research Alliance Corp. II
Index- P/E- EPS (ttm)-0.04 Insider Own3.23% Shs Outstand19.19M Perf Week-0.20%
Market Cap187.57M Forward P/E- EPS next Y- Insider Trans-6.22% Shs Float14.95M Perf Month0.10%
Income-0.70M PEG- EPS next Q- Inst Own92.60% Short Float0.01% Perf Quarter-0.10%
Sales- P/S- EPS this Y- Inst Trans-0.09% Short Ratio0.01 Perf Half Y-2.00%
Book/sh7.56 P/B1.30 EPS next Y- ROA-0.50% Target Price- Perf Year-
Cash/sh0.04 P/C234.47 EPS next 5Y- ROE-0.50% 52W Range9.64 - 10.31 Perf YTD0.31%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-4.90% Beta-
Dividend %- Quick Ratio5.00 Sales past 5Y- Gross Margin- 52W Low1.66% ATR0.03
Employees- Current Ratio5.00 Sales Q/Q- Oper. Margin- RSI (14)53.85 Volatility0.00% 0.11%
OptionableNo Debt/Eq0.00 EPS Q/Q-866.20% Profit Margin- Rel Volume0.93 Prev Close9.80
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume171.96K Price9.80
Recom- SMA200.22% SMA500.42% SMA200-2.02% Volume159,987 Change0.05%
Nov-12-21 10:03AM  
May-17-21 08:00AM  
Apr-28-21 09:07AM  
Mar-22-21 02:30PM  
Research Alliance Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It identifies and acquires a business, focusing on the healthcare industry, such as in biotechnology sector. Research Alliance Corp. II was incorporated in 2020 and is based in Las Vegas, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saba Capital Management, L.P.10% OwnerJun 28Sale9.8040,990401,7021,909,584Jun 29 09:29 AM